Table 2.
Outcomes up to August 5th, 2020, for Patients With COVID-19 Seen by the GAP Team that Were Still Hospitalized at the End of the Study Period
| Operational Metric/Outcomes | No (%) |
|---|---|
| No. | 58 |
| No. of follow-up visits | 44 |
| Consult to discharge average | 31 |
| LOS,a average | 41.9 |
| Any ICU stay | 40 (69) |
| All mortality | 22 (37.9) |
| All ICU mortality | 17 (29.3) |
| Discharge disposition | |
| Home | 7 (12.1) |
| Rehabilitation center | 22 (37.9) |
| Nursing home | 0 |
| Expired | 22 (37.9) |
| Home with hospicea | 3 (5.2) |
| Inpatient hospiceb | 1 (1.7) |
| Other | 1 (1.7) |
| Admitted | 2 (3.4) |
Abbreviations: COVID-19 = coronavirus disease 2019; GAP = geriatrics and palliative medicine; LOS = length of stay; ICU = intensive care unit.
LOS begins with admission time and ends with discharge time, time of death, or midnight on the last day of data collection for the study. It does not include time in the emergency department.
For this study, hospice, refers to an insurance benefit provided in the U.S. for patients believed to have a terminal illness process (with a possible life expectancy of less than 6 months) and where disease-modifying treatments are not possible or looked for by the patient. This benefit provides support services that are delivered by a multidisciplinary team and that focus on improving quality of life. Hospice care is provided wherever a patient resides.
Inpatient hospice care refers to services provided by this insurance program, in a specialized facility, for patients having intractable symptoms that otherwise cannot be provided wherever they reside.